Migraine without aura includes all of the symptoms and phases of a migraine attack, but without the visual, sensory, language, or motor symptoms that are classified as aura. An attack of migraine ...

Those who have migraine with aura experience neurological symptoms (the aura) 5 to 60 minutes before the headache. In some cases, these symptoms may continue during the headache phase. Visual ...

Migraines often go through four stages: prodrome, aura, headache, and postdrome. Prodrome involves early warning signs such as mood changes or cravings. Aura can include visual or sensory issues.

The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

A history of migraine, with or without aura, was a significant risk factor for open-angle glaucoma onset among a cohort of ...

Symbravo is not substitutable with other formulations of meloxicam or rizatriptan. The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment ...

Meloxicam is a nonsteroidal, anti-inflammatory molecule developed with Axsome’s Molecular Solubility Enhanced Inclusion ...

Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced protective effect for ischemic stroke.

The FDA has approved Axsome Therapeutics’ Symbravo (meloxicam and rizatriptan), a novel acute treatment for adults with migraine with or without aura. According to the company, Symbravo employs Axsome ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.